big pharma game

The making of a modern pharma blockbuster

September 11, 2015
Medical Communications Big Pharma, Twice Circled, computer game

The pharma industry divides opinions on its morality, but what has always stood out is the fact that in this …

Proteus system

US FDA accepts first digital medicine application

September 11, 2015
Medical Communications FDA, NDA, Otsuka, digital, digital medicine, proteus

The FDA has accepted the first New Drug Application for a digital medicine: Otsuka and Proteus Digital Health’s collaboration of …

Naomi Landman

Supply chain leaders call for forward pharma thinking

September 11, 2015
Manufacturing and Production, Medical Communications fly pharma, fly pharma conference, logistics, supply chain

Logistics companies must improve their understanding of the pharma industry to better serve their customers, according to a supply chain …

david_thompson

Envision Pharma acquires two medical education specialists in takeover deal

September 11, 2015
Medical Communications

Two principals from Alligent Biopharm Consulting have joined the UK communications group Envision Pharma following an acquisition deal.Alligent’s two principals, …

lab sign

Medimmune and Cancer Research UK launch new drug discovery lab

September 11, 2015
Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman

MedImmune and the UK’s biggest cancer charity have opened a new laboratory for joint cancer research.Research at the laboratory, which …

body scan

Pfizer in metabolic disease push

September 11, 2015
Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity

Pfizer has signed a research collaboration with a global medical health technology company, to investigate risk factors for metabolic conditions.  …

zs-pharma-logo_cmyk

Actelion confirms takeover talks with ZS Pharma

September 11, 2015
Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions

Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …

lyrica

High Court rules against Pfizer in Lyrica patent case

September 10, 2015
Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin

The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …

john_jeans

EM Imaging appoints new chairman

September 10, 2015
Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology

The board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans as non-executive …

Mylan building

Mylan to relaunch $27.1bn hostile takeover of Perrigo

September 10, 2015
Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover

Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …

Truvada pill

Gilead’s Truvada prevents HIV infections in high-risk men

September 10, 2015
Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections

UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …

GSK begins work on £100m India facility

September 9, 2015
Manufacturing and Production GlaxoSmithKline, India, manufacturing

GSK has begun work on its new Rs. 1000 crore (£100m) pharmaceutical factory in Vemgal, southern India. When fully operational …

Westminster

Pharma leaders urge UK Government not to cut spending

September 9, 2015
Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding

Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …

Alzheimer's research

Neurimmune kicks off late-stage Alzheimer’s study

September 9, 2015
Research and Development Alzheimer's disease, Biogen, Neurimmune, aducanumab, neurology

Neurimmune and its development partner Biogen are beginning a Phase III study of the companies’ potential Alzheimer’s treatment aducanumab.  The …

asthma inhalers

GSK suffers Breo late-stage trial blow

September 9, 2015
Research and Development COPD, GSK, Revlar, asthma, breo, clinical trial, phase III

GSK has hit a setback in its plans to expand sales of its blockbuster asthma treatment Breo, after a major …

michael_koslowski_picture

Mission Therapeutics appoints new chief medical officer

September 9, 2015
Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics

Mission Therapeutics has announced the appointment of Dr Michael Koslowski as chief medical officer. Dr Koslowski brings over 15 years’ …

unisa_research_building

Yabao Pharmaceutical and UniSA embark on joint venture

September 9, 2015
Research and Development Cancer, Yabao Pharmaceutical

Yabao Pharmaceutical and the University of South Australia (UniSA) have joined together in a collaboration to develop new treatments for …

Biocair International Ltd achieves AEO approval

September 8, 2015
Medical Communications Biocair

We are pleased to announce that as of 8th September 2015 Biocair International Ltd is an Authorised Economic Operator (AEO). …

The Gateway to Local Adoption Series

Latest content